Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?

• Patrick Chun Hean Tang,

  Affiliation Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia

  ⨯
• Wern Hann Ng,

  Affiliation Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia

  ⨯
• Nicholas J. C. King,

  Affiliations Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia, The Discipline of Pathology and Bosch Institute, School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia, Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia

  ⨯
• Suresh Mahalingam

  * E-mail: s.mahalingam@griffith.edu.au

  Affiliation Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia

  https://orcid.org/0000-0003-3141-8410

  ⨯